QuantBio LP is a hedge fund based in New York, New York. According to its most recent Form D, filed Sep 25, 2026, the fund has sold $36,376,333 of interests to 30 investors since its first sale in Apr 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Jean-Pierre Naegeli; Andrew Rubinstein.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $36,376,333Cumulative sales reported on Form D
- Investors
- 30
- First sale
- Apr 1, 2024
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Jean-Pierre Naegeli; Andrew Rubinstein
- Latest Form D
- Sep 25, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about QuantBio LP
What is the minimum investment for QuantBio LP?
QuantBio LP's latest Form D, filed Sep 25, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in QuantBio LP?
QuantBio LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has QuantBio LP raised?
QuantBio LP reports $36,376,333 sold from 30 investors on its Form D filed Sep 25, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is QuantBio LP based?
QuantBio LP is based in New York, New York.
When did QuantBio LP launch?
QuantBio LP reports its first sale in Apr 2024, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every hedge fund
Raised more than 38% of the 2,544 hedge funds based in New York, and more than 40% of all 10,308 that report sales.
Other funds with the same team
More hedge funds in New York
Similar-size hedge funds in New York
- iCapital-Point72 Capital Access Fund, L.P.$36.3M
- HF Diversifiers Series - HedgeForum Portfolios, LLC$36.4M
- Arini Diversified Alpha US Fund LP$36.2M
- iCapital-WorldQuant Millennium US Active Extension Offshore Access Fund, Ltd.$36.5M
- RichBrook Offshore Segregated Portfolio B - Illiquid MBS/ABS Fund$36.0M
- G2 New Issue Fund QP LP$37.2M